FindTrial
Sign In

An observational study on vatrakt due to Diwaswap and Ratrijagran

An Observational study of Hetu of Vatrakta with special reference to Diwaswap and Ratrijagrana - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/102554
Enrollment
60
Registered
2026-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Dr.Surekha Janu Hirole
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed Patients of Vatarakta will be selected. Patients between 18 to 50 years of Age will be selected. Patients will be selected irrespective of their gender religion occupation education socio economic status and area of habitat. Patient willing to participate in the study with written informed consent.

Exclusion criteria

Exclusion criteria: Patients having disorders such as Hypertension, Diabetes Mellitus, Hypothyroidism and Carcinoma. Pregnant and lactating mothers will be excluded

Design outcomes

Primary

MeasureTime frame
To study role of Diwaswap and Ratrijaagarana as a Hetu of VataraktaTimepoint: At enrollment—

Secondary

MeasureTime frame
To study Nidanpanchak of Vatarakta in detail Timepoint: At enrollment—

Countries

India

Contacts

Public ContactDr Surekha Janu Hirole

Radhakisan Toshniwal Ayurved Mahavidyalaya Akola

upathyaydrsapna@gmail.com8275287035

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026